[Federal Register Volume 64, Number 88 (Friday, May 7, 1999)]
[Notices]
[Page 24712]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-11504]


-----------------------------------------------------------------------

DEPARTMENT OF VETERANS AFFAIRS


Research and Development Cooperative Studies Evaluation 
Committee; Notice of Meeting

    The Department of Veterans Affairs gives notice under Public Law 
92-463 (Federal Advisory Committee Act) as amended, by section 5(c) of 
Pub. L. 94-409, that a meeting of the Research and Development 
Cooperative Studies Evaluation Committee will be held at the Marriott 
Residence Inn, 500 Army Navy Drive, Arlington, VA 22202, May 11-13, 
1999. The session on May 11 will begin at 7:30 a.m. until 5:45 p.m., on 
May 12 from 7:30 a.m. until 5:00 p.m. and on May 13 from 7:30 a.m. 
until 12:00 noon. The meeting will be for the purpose of reviewing the 
following six new proposals: treatment of knee osteoarthritis, Type II 
Diabetes, statins in reducing the risk of stroke, Pallidal procedure 
for Parkinson's disease, homocysteinemia in kidney and end stage renal 
disease, and genetic tissue banking in clinical research. The Committee 
will also review the progress of four on going studies on 
Antiarrhythmic Therapy, group treatment of PTSD, computer-assisted 
neuropsychological screening battery and Naltrexone treatment of 
alcoholism.
    The Committee advises the Chief Research and Development Officer 
through the Chief of the Cooperative Studies Program on the relevance 
and feasibility of the studies, the adequacy of the protocols, and the 
scientific validity and propriety of technical details, including 
protection of human subjects.
    The meeting will be open to the public from 7:30 a.m. to 8:00 a.m. 
on all three days to discuss the general status of the program. Those 
who plan to attend should contact Dr. Ping Huang, Coordinator, Research 
and Development Cooperative Studies Evaluation Committee, Department of 
Veterans Affairs, Washington, DC, (202-273-8295).
    The meeting will be closed during the following portions: on May 
11, from 8:15 a.m. until 5:45 p.m., on May 12, from 8:00 a.m. until 
5:00 p.m. and on May 13 from 8:00 a.m. until 12:00 noon. These portions 
of the meeting involve consideration of specific proposals in 
accordance with provisions set forth in section 10(d) of Pub. L. 92-
463, as amended by Pub. L. 94-409, and 5 U.S.C. 552b(c)(6) and (9)(B). 
During the closed sessions of the meeting, discussions and 
recommendations will deal with qualifications of personnel conducting 
the studies (the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy), as well as staff and 
consultant critiques of research protocols, and similar documents, and 
the medical records of patients who are study subjects (the premature 
disclosure of which would significantly frustrate implementation of 
proposed agency action regarding such research projects).

    Dated: May 3, 1990.

    By Direction of the Secretary.
Heyward Bannister,
Committee Management Officer.
[FR Doc. 99-11504 Filed 5-6-99; 8:45 am]
BILLING CODE 8320-01-M